Trxade Well being (MEDS) Q2 2024 Analysis Abstract
Trxade Well being, Inc. (NASDAQ: MEDS) is a drug procurement and supply platform with a mission to revolutionize the healthcare ...
Friday, April 25, 2025
Tag: TRxADE
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy ...
Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform
Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be ...
MEDS Earnings: Trxade Health loss narrows in Q1 2023; revenue down 31%
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter ...
TRxADE HEALTH Inc (MEDS) Q4 2022 Earnings Call Transcript
TRxADE HEALTH Inc (NASDAQ:MEDS) Q4 2022 Earnings Call dated Mar. 27, 2023. Corporate Participants: Prashant Patel — Chief Financial Officer Surendra Ajjarapu — Founder, ...
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. ...
Trxade explores alternative ways to find partners for B2C assets: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company that is on a mission to enable independent pharmacies ...
TRxADE HEALTH, Inc. (MEDS) This autumn 2021 Earnings Name Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) This autumn 2021 earnings name dated Mar. 28, 2022 Company Individuals: Howard Doss — Chief Monetary Officer Suren ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.